Background and purpose: There have been no large-scale studies on the impact of diabetes mellitus (DM) on outcomes in Japanese patients undergoing coronary artery bypass grafting (CABG). Methods and subjects: A multi-institutional retrospective cohort study was conducted in 14 Japanese centers. All adult patients who underwent isolated CABG from 2007 to 2008 were included (n = 1522, mean age: 68.5 years). The definitions of DM were all patients admitted with diagnosis of DM and preoperative glycated hemoglobin (Hb) A1c ≥ 6.5%. Univariate and multivariate analyses were performed to identify the risk of morbidity and mortality. Results: There were 849 DM and 572 non-DM patients. Preoperative mean HbA1c were 7.1% in the DM group and 5.7% in the non-DM group (p < 0.0001). Preoperative, intraoperative, and 3-day average postoperative blood glucose (BG) were 146 mg/dl, 172 mg/dl, and 168 mg/dl in the DM group, and 103 mg/dl, 140 mg/dl, and 136 mg/dl in the non-DM group (all p < 0.0001). Although there were no significant differences in postoperative cardiovascular events, the incidence of infection was significantly higher in the DM group than in the non-DM group (9.2% vs 6.1%, p = 0.036) on the univariate analysis. The all-cause death was also relatively higher in the DM group than in the non-DM group (2.1% vs 1.1%, p = 0.12), and this was likely related to infection. Conclusion: DM patients had worse perioperative BG control, higher incidence of infection, and higher mortality than non-DM patients. These results indicate that perioperative BG control guidelines should be standardized to obtain better surgical outcomes in Japanese DM patients.
Introduction
The prevalence of diabetes mellitus (DM) has increased dramatically in Western countries over the past several decades, leading in turn to increased mortality due to cardiovascular events [1] . This trend is also apparent in Asian countries, especially in Japan, where the number of DM patients has increased from 6.9 million to 8.9 million in the past decade (a 29% increase) [2] . The most important life-threatening complication in DM patients is obviously coronary artery disease [3] . There has been debate regarding the optimal treatment for DM patients; some physicians favor percutaneous catheter intervention (PCI), while others favor coronary artery bypass grafting (CABG). Some studies have shown that CABG yields better long-term outcomes in DM patients with multivessel disease [4, 5] . However, it is well known that patients with DM who undergo CABG have worse early and late outcomes than CABG patients without DM [6, 7] . Also, it has been shown that intraoperative and postoperative blood glucose (BG) control has a significant effect on complications such as infection and mortality [8] [9] [10] . However, there have been no large-scale studies on Japanese DM patients undergoing CABG. To better understand the impact of DM on coronary artery surgery and to establish the optimal BG control method during cardiac surgery, we organized a multicenter/multidisciplinary research group, which we called the JMAP study group (Japanese Study to Explore the Impact of Diabetes on Cardiac Surgery for Optimal Glycemic Control Protocol). Herein, we carried out a retrospective cohort study to identify the impact of DM and BG control on surgical outcomes in Japanese patients undergoing CABG.
Materials and methods
From 2007 to 2008, a total of 1522 patients underwent isolated CABG in 14 cardiac surgery centers including 10 university hospitals (Appendix I) in Japan. Patients who underwent redo CABG were included, but patients who underwent concomitant procedures such as valvular procedures, aneurysm repair, arrhythmia surgery, repair of ventricular septal perforation, and surgical ventricular restoration procedures were excluded from this study. The number of the cases enrolled in each hospital varied from 8 to 365, also the number of the operating surgeons ranged from one to three. All the patient characteristics and operative data were extracted from the prospective national database (the Japan Adult Cardiovascular Surgery Database: JACVSD), which is similar to the Society of Thoracic Surgeons (STS) national database in North America. Other study-specific data like preoperative glycated hemoglobin (Hb)A1c and perioperative BG control, as well as other blood laboratory data and postoperative complications including cardiovascular events and individual infections, which are not included in the JACVSD, were obtained from medical records at each study site. These two sets of data were merged, then blinded, and sent to a data center (the EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan).
Demographic variables are listed in Appendix II. Of note, the Japanese Diabetes Society (JDS) value of HbA1c (%) is converted into the National Glycohemoglobin Standardization Program (NGSP) equivalent value (%) calculated by the following formula according to the JDS guidelines [11] :
Postoperative variables were acute myocardial infarction (MI), cerebrovascular events, acute renal failure, and other cardiovascular events (including cardiac tamponade, ventricular tachycardia or fibrillation, and complications after PCI). Postoperative infection was categorized into deep sternal wound infection (anterior mediastinitis), superficial sternal wound infection, graft harvesting site infection, blood stream infection, urinary tract infection, and pneumonia. Details of the definitions of the clinical events are summarized in Appendix III. Hospital death included allcause death within 30 days of operation or during initial hospitalization. All the aforementioned clinical events were evaluated at the participating centers, and then assessed by the independent clinical events evaluation committee (Appendix IV) if necessary. The primary composite endpoint was defined as a composite of acute MI, cerebrovascular accidents, other cardiovascular events, all infections and their related deaths. Although cardio-cerebrovascular events were thought to be important for DM patients, this prespecified primary composite endpoint was not related to DM. Thus, we added a new composite endpoint (the additional composite endpoint), which consisted of all infections, acute renal failure, and all-cause deaths, and conducted a post hoc analysis.
DM patients were defined as those patients who were admitted to the participating hospitals with a diagnosis of DM. Patients without a previous diagnosis of DM who had preoperative HbA1c ≥ 6.5% (NGSP) were also included [12] . The intraoperative BG was an average of 3-4 BG measurements taken during surgery. In the intensive care unit, the frequency of BG measurement was similar among the participating hospitals: BG was measured every 2-4 h in patients with intravenous continuous insulin infusion, and at least 4 times in non-diabetic patients without insulin. The postoperative 3-day BG average was a composite average of the daily mean BG levels (BG was measured up to 12 times per day following surgery) from the day of the surgery to postoperative day 3.
Perioperative BG control methods varied from hospital to hospital, however, in all the participating institutions, it was standard practice to treat hyperglycemia with continuous insulin infusion whenever BG exceeded 200 mg/dl. Preoperative renal insufficiency was defined as an increased serum creatinine level equal to or more than 2.0 mg/dl. The internal thoracic arteries were harvested by means of skeletonized fashion using the Harmonic Scalpel (Ethicon, West Somerville, NJ, USA) in most of the participating centers. In terms of intraoperative steroid use, a large amount of steroid (methylprednisolone 500-1000 mg) was primed in a cardiopulmonary bypass circuit in some centers for on-pump CABG cases. Also, some surgeons and anesthesiologists preferred to give a moderate amount of intravenous steroid (methylprednisolone 125-500 mg) immediately after starting off-pump CABG cases to prevent systemic inflammatory responses.
Statistical analyses
Baseline characteristics of the DM and the non-DM groups are described as mean ± standard deviation for continuous variables and proportions for categorical variables. p-Values were calculated by the t-test and the chi-squared test. We compared the proportions of primary and additional composite endpoints and their components between the DM and the non-DM groups. Risk ratios and associated 95% confidence intervals were calculated.
Logistic regression analyses were conducted to estimate the magnitude of the effect of DM on the additional composite endpoint, all infections, and all-cause deaths adjusted by age (in 10-year increments), gender, body mass index, congestive heart failure, renal insufficiency, chronic obstructive pulmonary disease, peripheral artery disease, left ventricular ejection fraction < 50%, operative status (elective vs urgent or emergency), bilateral internal thoracic artery use, and intraoperative steroid use. Of note, these factors were prefixed before the statistical analyses. Odds ratios and their associated 95% confidence intervals were calculated. All analyses were performed with JMP 8.0 statistics software (SAS Institute Inc., Cary, NC, USA). The two-sided alpha level was set to 5%.
This study was approved by the Internal Review Board at all the participating hospitals and the Ethics Committee of the Kyoto University Graduate School and Faculty of Medicine. All the patients and their families gave written consent at the time of operation for participation in the JACVSD.
Results
A total of 1522 enrolled patients were classified into two groups: the DM group (n = 849) and the non-DM group (n = 572). Because there were no preoperative HbA1c data for 101 patients without a previous diagnosis of DM, these patients were excluded from this study. The preoperative management of BG in the DM group included subcutaneous insulin injection in 254 patients (29.9%), oral medications in 342 (40.3%), and diet regulation in 233 (27.4%). Patients' baseline characteristics are shown in Table 1 . There were no differences in terms of age, gender, and body mass index (BMI). However, depressed left ventricular systolic function (ejection fraction < 50%), renal insufficiency, and peripheral artery disease were significantly higher in the DM group than in the non-DM group. On the other hand, chronic obstructive pulmonary disease was less common in the DM group. There was no difference in terms of usage of bilateral internal thoracic artery, however intraoperative administration of intravenous steroids was more common in the non-DM group. There were no differences in operative status. Offpump technique was used frequently in both groups (about 70% of patients in each group).
Preoperative mean HbA1c were 7.1% in the DM group and 5.7% in the non-DM group (p < 0.0001). Also, preoperative fasting, intraoperative, and 3-day average postoperative BG were 146 mg/dl, 172 mg/dl, and 168 mg/dl in the DM group, and 103 mg/dl, 140 mg/dl, and 136 mg/dl in the non-DM group, respectively. At all measurement points, DM patients had significantly higher BG levels (p < 0.0001). In terms of postoperative BG control, 71% of the patients in the DM group were treated with continuous insulin infusion whereas only 22% of the patients in the non-DM group were treated with continuous insulin infusion. As shown in Table 2 , the all-cause deaths were 2.1% (n = 18) in the DM group and 1.1% (n = 6) in non-DM group (p = 0.124). There was no significant difference in the primary composite endpoint, however, the additional composite endpoint was significantly higher in the DM group. In terms of complications, although there were no significant differences in the incidence of postoperative cardiovascular events and cerebrovascular accidents, the incidence of overall infection was significantly higher in the DM group than in the non-DM group (9.2% vs 6.1%, primary composite endpoint included female gender and renal insufficiency ( Table 3 ). The statistically significant risk factors for the additional composite endpoint included female gender, BMI, renal insufficiency, and chronic obstructive pulmonary disease (Table 4) . Also, the statistically significant risk factors for overall infection were female gender, BMI, and renal insufficiency (Table 5) . Finally, the statistically significant preoperative or operative risk factors for all-cause death were renal insufficiency, congestive heart failure, and emergency surgery ( Table 6 ). The presence of DM was not identified as a statistically significant independent risk factor on multivariate analyses for the composite endpoints and complications including overall infection and all-cause death which were linked to DM on the univariate analyses. On the other hand, it became apparent that preoperative renal insufficiency was a very strong common risk factor for both overall infection and all-cause death.
Discussion
In 2009, the Society of Thoracic Surgeons Blood Glucose Management Task Force published their guidelines regarding BG management during adult cardiac surgery [13] . According to these guidelines, it is highly desirable to maintain BG < 180 mg/dl during surgery and during the immediate postoperative period with intravenous insulin infusion in DM patients. Although it is unnecessary to use intravenous continuous insulin infusion in non-DM patients during surgery, both DM and non-DM patients benefit from maintaining BG < 180 mg/dl in order to prevent morbidity and mortality [13] . This begs the question of how low the target should be. Furnary et al. reported from their prospective observational study that there was a highly significant relationship between mortality and postoperative glucose levels rising above 175 mg/dl [10] . Our current BG levels in DM patients were barely below this cut-off value, given the intraoperative and postoperative 3-day average BG were 172 mg/dl and 168 mg/dl, respectively. Therefore, there seemed to be some room to lower the BG levels further, which potentially would reduce the morbidity and the mortality in the DM patients.
It has been reported that the presence of DM in patients undergoing CABG is a significant risk factor for hospital mortality and morbidity including stroke, deep sternal wound infection, and length of hospital stay from the STS database analyses [14] . In addition, DM patients have worse long-term survival than non-DM patients after surgery [6] . Our results from univariate analyses show that DM has a significant influence on the additional composite endpoint consisting of all-cause death, overall infection, and acute renal failure (10.8% vs 7.3%, p = 0.027). Looking at each complication, overall infection was the most significant factor contributing to this result (9.2% in DM group vs 6.1% in non-DM group, p = 0.036). Also, DM patients tended to have higher mortality than non-DM patients (2.1% vs 1.1%, p = 0.124). Moreover, DM patients tended to have a much higher incidence of deep sternal wound infection than non-DM patients (2.0% vs 1.1%, p = 0.163), although this difference did not reach statistical significance. However, the complication of infection definitely influenced mortality rates because the majority of deaths were related to infection in the DM group. There is no doubt that DM patients have unfavorable baseline characteristics such as diffuse coronary artery disease, peripheral artery disease, high BMI, and worse preoperative renal function, all of which would contribute to worse short-and long-term outcomes compared to non-DM patients.
Our multivariate logistic regression analyses failed to identify DM as an independent risk factor for any of the complications including overall infection and all-cause death. This is most likely because some other preoperative risk factors such as renal insufficiency (predominantly in the DM group) and chronic obstructive pulmonary disease (predominantly in the non-DM group) had too much influence to each endpoint, which attenuated the impact of the presence of DM. This is one of the well-known downsides of the logistic regression models. In fact, the prevalence of preoperative renal insufficiency in this study population is much higher (13.8% in the DM group) than that of other studies published in the literature [10] . It should also be noted that 85 patients (5.6% of all study patients) predominantly in the DM group had been on chronic hemodialysis preoperatively, which must have given great impact to the multivariate analyses. We are now in the process of doing a sub-analysis in this regard to identify the relative impact of the presence of preoperative renal insufficiency.
The Portland Diabetic Project, which is an on-going prospective study of over 5000 DM patients, aims to show that tight glucose control from the end of surgery until the 2nd postoperative day with continuous insulin infusion may eliminate the diabetic disadvantage [15] . They showed that tight glucose control with a full 3 days of continuous insulin infusion (the Portland Protocol) significantly reduced mortality (by 65%), deep sternal wound infection (by 63%), and length of hospital stay (average 2-day reduction). Therefore, they concluded that DM is not the true risk factor for the seemingly unfair diabetic disadvantage in terms of increased mortality and morbidity. Since we showed that DM patients still have excess mortality and morbidity compared to non-DM patients in the current study, we might be able to reduce these excess complications by implementing tighter glucose control protocols.
It has been debated whether intensive BG control is better than conventional BG control. In a landmark paper, van den Berghe et al. conducted the first prospective randomized trial comparing tight BG control (target 80-110 mg/dl) with intensive insulin therapy to conventional BG control in critically ill surgical patients [16] . They demonstrated that tight BG control resulted in a significant reduction in mortality (10.6% with intensive treatment vs 20.2% with conventional treatment, p = 0.005), exclusively in those patients who required ≥5 days of intensive care unit (ICU) care with multiorgan failure and sepsis. Also, cardiac surgical mortality was reduced in those patients requiring ≥3 days of ICU care. D'Alessandro et al. reported a propensity analysis that showed that strict BG control significantly reduced the EuroSCORE expected mortality in DM patients undergoing CABG, especially in moderate-to high-risk patients [17] . Their BG target in the operating room and ICU were 150-200 mg/dl and ≤140 mg/dl, respectively. In terms of long-term outcomes, Lazar et al. showed that tight perioperative glucose control with glucose-insulin-potassium solution improved not only perioperative outcomes, but also long-term survival and freedom from recurrent angina [18] . These studies clearly demonstrate the superiority of tight BG control over conventional control, especially in critically ill patients. On the other hand, Gandhi et al. showed in a prospective randomized study on 400 patients undergoing CABG, including non-DM patients, that intraoperative intensive insulin therapy with a target range of 80-100 mg/dl did not reduce perioperative mortality and morbidity, but rather increased stroke rate and mortality [19] . Furthermore, a meta-analysis of 29 randomized studies focusing on the benefits and risks of tight glucose control in critically ill adult patients concluded that tight glucose control was not associated with significantly reduced hospital mortality but was associated with an increased risk of hypoglycemia [20] . To support these results, a recent prospective randomized multicenter trial (the NICE-SUGAR study) demonstrated that intensive BG control with a target of 81-108 mg/dl increased mortality among adults in the ICU compared with conventional BG control with a target of 180 mg/dl or less [21] . In this study, however, the mortalities in the intensive control group and conventional control group were 27.5% and 24.9% at 90 days after randomization, respectively. In both groups, potentially life-sustaining treatments were withheld or withdrawn in more than 90% of the patients who died. Also, it seems that severe hypoglycemia commonly occurred in the intensive BG control group of the study, which may raise the question of the safety and feasibility of the tight glucose control protocol itself. Because these patients in the study were so sick at the time of enrollment, it is difficult to compare the results of these studies with studies on regular cardiac surgery patients, given the current acceptable mortality after CABG of around 1-2%. It may be necessary to conduct a prospective randomized study to compare tight glucose control and conventional glucose control using more sophisticated protocols with a minimum risk of hypoglycemia in exclusively cardiac surgery patients to reach a definitive conclusion, which we are currently planning to initiate as a next step to our ultimate goal.
Perhaps, one of the other interesting features of this multi-center study is the fact that about 70% of all isolated CABG procedures were performed using the off-pump technique in both the DM and non-DM groups. This trend is far above the typical rates in North America, given the fact that the adoption of off-pump CABG was only 21.8% in 2009 according to the STS database [22] . A systematic review and meta-analysis of propensity score analyses in more than 123,000 patients comparing offpump and on-pump CABG demonstrated that off-pump provides favorable outcomes in mortality, stroke, renal failure, wound infection, blood transfusion, intraaortic balloon pump support, and prolonged ventilation [23] . It will be interesting to see the impact of off-pump techniques in DM patients in terms of not only preoperative, intraoperative, and postoperative glucose control, but also in terms of postoperative complications and related mortality [24] . We are also planning to perform a post hoc subgroup analysis focusing on this in the near future.
There are several limitations to this study. This was a retrospective, observational study, and hence unknown patient selection processes may cause a bias. Importantly, there was no standard BG control protocol across the participating hospitals. Our sample size was relatively large, however, it was not large enough to stratify the level of perioperative BG control as an indicator of risk events. In fact, we were unable to show any difference in terms of the morbidity and mortality according to the level of intraoperative and postoperative BG control due to too few complications.
Conclusions
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